Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study.

Additionally, plasmacytoma and del (17p) were risk factors, but they did not reach statistical significance, with HRs of 2.07 (95% CI, 0.74–5.79; p = 0.164) and 1.92 (95% CI, 0.75–4.87, p = 0.172), respectively.

also in 111,027 other papers